<link rel="stylesheet" href="styles.84630ab4f3c563f3.css"> Skip to main

Federal Register of Legislation annual survey

Have your say on the Federal Register of Legislation. Complete our annual survey and tell us about your experience using the Register.

Designation of Adalimumab (HUMIRA) as an Orphan Drug - AbbVie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2012G0025514 November 2012

Legislation text